These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32975182)

  • 1. SARS-CoV-2 Serosurvey in Addis Ababa, Ethiopia.
    Kempen JH; Abashawl A; Suga HK; Nigussie Difabachew M; Kempen CJ; Tesfaye Debele M; Menkir AA; Assefa MT; Asfaw EH; Habtegabriel LB; Sitotaw Addisie Y; Nilles EJ; Longenecker JC
    Am J Trop Med Hyg; 2020 Nov; 103(5):2022-2023. PubMed ID: 32975182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 in Ethiopia: A contextual approach to explaining its slow growth.
    Wondimagegn D; Petros A; Asrat Y; Aklilu T; Estifanos AS; Addissie A; Amogne W; Gebremariam TH; Cartmill C; Whitehead C; Soklaridis S; Yifter H
    J Glob Health; 2020 Dec; 10(2):020369. PubMed ID: 33110563
    [No Abstract]   [Full Text] [Related]  

  • 3. Are we underestimating seroprevalence of SARS-CoV-2?
    Burgess S; Ponsford MJ; Gill D
    BMJ; 2020 Sep; 370():m3364. PubMed ID: 32883673
    [No Abstract]   [Full Text] [Related]  

  • 4. Seroprevalence and risk factors for SARS-CoV-2 Infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July 2020.
    Tadesse EB; Endris AA; Solomon H; Alayu M; Kebede A; Eshetu K; Teka G; Seid BE; Ahmed J; Abayneh SA; Moges B; Gerawork H; Sugerman D; Assefa Z; Abayneh A; Abate E; Taddese L
    Int J Infect Dis; 2021 Oct; 111():179-185. PubMed ID: 34411720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.
    Murhekar MV; Bhatnagar T; Selvaraju S; Rade K; Saravanakumar V; Vivian Thangaraj JW; Kumar MS; Shah N; Sabarinathan R; Turuk A; Anand PK; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Rangaraju C; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Salim Khan SM; Haq I; Kumar MS; Laxmaiah A; Madhuka ; Mahapatra A; Mitra A; Nirmala AR; Pagdhune A; Qurieshi MA; Ramarao T; Sahay S; Sharma YK; Shrinivasa MB; Shukla VK; Singh PK; Viramgami A; Wilson VC; Yadav R; Girish Kumar CP; Luke HE; Ranganathan UD; Babu S; Sekar K; Yadav PD; Sapkal GN; Das A; Das P; Dutta S; Hemalatha R; Kumar A; Narain K; Narasimhaiah S; Panda S; Pati S; Patil S; Sarkar K; Singh S; Kant R; Tripathy S; Toteja GS; Babu GR; Kant S; Muliyil JP; Pandey RM; Sarkar S; Singh SK; Zodpey S; Gangakhedkar RR; S Reddy DC; Bhargava B
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):48-60. PubMed ID: 32952144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020.
    Bogogiannidou Z; Vontas A; Dadouli K; Kyritsi MA; Soteriades S; Nikoulis DJ; Mouchtouri VΑ; Koureas M; Kazakos EI; Spanos EG; Gioula G; Ntzani EE; Eleftheriou AA; Vatopoulos A; Petinaki E; Papaevangelou V; Speletas M; Tsiodras S; Hadjichristodoulou C
    Euro Surveill; 2020 Aug; 25(31):. PubMed ID: 32762796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG.
    Sapkal G; Shete-Aich A; Jain R; Yadav PD; Sarkale P; Lakra R; Baradkar S; Deshpande GR; Mali D; Tilekar BN; Majumdar T; Kaushal H; Gurav Y; Gupta N; Mohandas S; Deshpande K; Kaduskar O; Salve M; Patil S; Gaikwad S; Sugunan AP; Ashok M; Giri S; Shastri J; Abraham P; Gangakhedkar RR;
    Indian J Med Res; 2020 May; 151(5):444-449. PubMed ID: 32611915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of active COVID-19 in Slovenia: a nationwide population study of a probability-based sample.
    Maver Vodičar P; Oštrbenk Valenčak A; Zupan B; Avšič Županc T; Kurdija S; Korva M; Petrovec M; Demšar J; Knap N; Štrumbelj E; Vehovar V; Poljak M
    Clin Microbiol Infect; 2020 Nov; 26(11):1514-1519. PubMed ID: 32688068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response.
    Siegler AJ; Sullivan PS; Sanchez T; Lopman B; Fahimi M; Sailey C; Frankel M; Rothenberg R; Kelley CF; Bradley H
    Ann Epidemiol; 2020 Sep; 49():50-60. PubMed ID: 32791199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study).
    Mesnil M; Joubel K; Yavchitz A; Miklaszewski N; Devys JM
    Anaesth Crit Care Pain Med; 2020 Oct; 39(5):595-596. PubMed ID: 32861816
    [No Abstract]   [Full Text] [Related]  

  • 13. Tracking Potential COVID-19 Outbreaks With Influenzalike Symptoms Urgent Care Visits.
    Muchmore B; Muchmore P; Lee CW; Alarcón-Riquelme ME; Muchmore A
    Pediatrics; 2020 Oct; 146(4):. PubMed ID: 32699069
    [No Abstract]   [Full Text] [Related]  

  • 14. Geographical Profiles of COVID-19 Outbreak in Tokyo: An Analysis of the Primary Care Clinic-Based Point-of-Care Antibody Testing.
    Takita M; Matsumura T; Yamamoto K; Yamashita E; Hosoda K; Hamaki T; Kusumi E
    J Prim Care Community Health; 2020; 11():2150132720942695. PubMed ID: 32674696
    [No Abstract]   [Full Text] [Related]  

  • 15. Issues to be considered when planning sero-epidemiological studies in regions with a low incidence of SARS-CoV-2.
    Wang J; Zhou M
    Am J Infect Control; 2020 Sep; 48(9):1127-1128. PubMed ID: 32562715
    [No Abstract]   [Full Text] [Related]  

  • 16. Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey.
    Adorni F; Prinelli F; Bianchi F; Giacomelli A; Pagani G; Bernacchia D; Rusconi S; Maggi S; Trevisan C; Noale M; Molinaro S; Bastiani L; Fortunato L; Jesuthasan N; Sojic A; Pettenati C; Tavio M; Andreoni M; Mastroianni C; Antonelli Incalzi R; Galli M
    JMIR Public Health Surveill; 2020 Sep; 6(3):e21866. PubMed ID: 32650305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 18. Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak.
    Metcalf CJE; Viboud C; Spiro DJ; Grenfell BT
    Trends Immunol; 2020 Oct; 41(10):849-851. PubMed ID: 32680648
    [No Abstract]   [Full Text] [Related]  

  • 19. Smoking in critically ill patients with COVID-19: the Australian experience.
    Plummer MP; Pellegrini B; Burrell AJ; Begum H; Trapani T; Udy AA;
    Crit Care Resusc; 2020 Sep; 22(3):281-283. PubMed ID: 32900337
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening Testing for SARS-CoV-2 upon Admission to Rehabilitation Hospitals in a High COVID-19 Prevalence Community.
    Kirshblum SC; DeLauter G; Lopreiato MC; Pomeranz B; Dawson A; Hammerman S; Gans BM
    PM R; 2020 Oct; 12(10):1009-1014. PubMed ID: 32700434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.